Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01773785 |
|---|---|
| Brief Title: | Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer |
| First Submitted : | January 14, 2013 |
| First Submitted that Met QC Criteria : | January 18, 2013 |
| First Posted : | January 23, 2013 (Estimate) |
| Certification/Extension First Submitted : | September 30, 2021 |
| Certification/Extension First Submitted that Met QC Criteria : | September 30, 2021 |
| Certification/Extension First Posted : | October 5, 2021 |
| Last Update Submitted that Met QC Criteria : | October 8, 2021 |
| Last Update Posted : | October 13, 2021 |